{"id":198029,"name":"PUBLIC SECTOR HEALTHCARE ROUNDTABLE","slug":"public-sector-healthcare-roundtable","state":"VA","country":"United States of America","description":"Representing the public sector purchaser health care policy interests","totalSpending":90000,"filings":29,"yearlySpending":[{"year":2018,"income":5000},{"year":2019,"income":0},{"year":2020,"income":0},{"year":2022,"income":0},{"year":2023,"income":0},{"year":2024,"income":35000},{"year":2025,"income":50000}],"issues":["PHA","HCR","MMM"],"firms":["HEALTHSPERIEN"],"lobbyists":["ANDREW MACPHERSON","CAROLYN KOWALYK"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Centers For Medicare and Medicaid Services (CMS)","Health & Human Services, Dept of (HHS)"],"sampleDescriptions":["Advocate for federal legislation to contain drug costs (s.974, s.3094).","Advocate for more sustainable pharmaceutical prices in the US (H.R.3) Advocate for the preservation and expansion of of Medicare Advantage Employer Group Waiver Plans.","Advocate for more sustainable pharmaceutical prices in the US (H.R.3) Advocate for the preservation and expansion of of Medicare Advantage Employer Group Waiver Plans.","Advocate for more sustainable pharmaceutical prices in the US (H.R.3) Advocate for the preservation and expansion of of Medicare Advantage Employer Group Waiver Plans.","Advocate for more sustainable pharmaceutical prices in the US (H.R.3) Advocate for the preservation and expansion of of Medicare Advantage Employer Group Waiver Plans."],"years":[2018,2019,2020,2022,2023,2024,2025]}